A Phase II, Single-Site, Open-Label Clinical Trial To Evaluate The Efficacy Of Kovacaine Mist Administered Unilaterally For Anesthetizing Maxillary Teeth In Healthy Dental Patients.

Trial Profile

A Phase II, Single-Site, Open-Label Clinical Trial To Evaluate The Efficacy Of Kovacaine Mist Administered Unilaterally For Anesthetizing Maxillary Teeth In Healthy Dental Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jan 2017

At a glance

  • Drugs Oxymetazoline/tetracaine (Primary)
  • Indications Procedural pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Apr 2012 Planned number of patients changed from 12 to 30 as reported by ClinicalTrials.gov.
    • 14 Feb 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 14 Feb 2012 Actual initiation date Jan 2012 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top